Archangels

Archangels, founded in 1992, holds the distinction of being the world's longest continuously operating business angel syndicate. With nearly three decades of investment experience, this pioneering organization has established itself as a cornerstone of Scotland's entrepreneurial ecosystem. The syndicate brings together sophisticated investors who collectively provide crucial early-stage capital to promising Scottish startups, helping bridge the funding gap that often challenges innovative companies in their formative stages.

The investment focus of Archangels centers primarily on intellectual property-rich ventures within the technology and life sciences sectors. Their portfolio encompasses diverse fields including software development, biopharmaceuticals, medical devices, and cutting-edge bionics. This strategic specialization allows the syndicate to leverage its members' deep domain expertise when evaluating potential investments and supporting portfolio companies through their growth journey.

Among Archangels' notable portfolio companies are CALCiViS, a dental imaging technology innovator; NCTech, a developer of 360-degree imaging systems; Optoscribe, a specialist in 3D photonic components; Reactec, a pioneer in workplace monitoring technology; and ZoneFox, a cybersecurity company that achieved a successful exit. These investments demonstrate the syndicate's ability to identify promising Scottish enterprises with significant growth potential and global market opportunities.

Beyond providing capital, Archangels offers portfolio companies valuable strategic guidance, industry connections, and operational expertise. The syndicate typically invests at seed and Series A stages, with members often participating in follow-on funding rounds to support sustained growth. This long-term investment approach has contributed to Scotland's reputation as a thriving innovation hub, particularly in Edinburgh where many of their portfolio companies are headquartered. Through their disciplined yet supportive investment philosophy, Archangels continues to play a vital role in transforming promising Scottish innovations into commercially successful enterprises.